DEVELOPMENT OF NEW PYRAZOLE HYBRIDS AS ANTITUBERCULAR AGENTS: SYNTHESIS, BIOLOGICAL EVALUATION AND MOLECULAR DOCKING STUDY

Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2017, Vol 9, Issue 10

Abstract

Objective: synthesis of new 1, 3-diphenyl pyrazole derivatives 9(a-f) and 10(a-f) using molecular hybridization approach for antitubercular and cytotoxic studies.Methods: The structures of synthesized compounds were confirmed by 1H-NMR, 13C-NMR and mass spectra’s. The antitubercular activity of compounds and standard drugs were assessed against Mycobacterium tuberculosis using microplate Alamar Blue assay (MABA).  The cytotoxic activities were performed by Sulforhodamine B (SRB) assay. The molecular docking and in silico ADME prediction were studied by using Schrodinger.Results: The results reveals that the compounds 9c, 9d, 10c and 10d exhibited substantial antitubercular potential with MIC < 20 μM. The cytotoxic studies revealed that the active compounds (9d, 10a, and 10d) are non-toxic to HeLa cancer cell lines with selectivity index >10. The molecular docking study was performed to study the binding orientation and affinity of synthesized compounds for InhA enzyme.Conclusion: The study explored that the 1, 3-diphenyl pyrazole hybrids coupled with well known antitubercular drugs could be a potential lead for antitubercular agents. In-silico molecular docking study helps to identify their corresponding intermolecular ligand-protein interactions with target enzyme. Also ADME prediction studies revealed that the compounds were in acceptable range to have pharmacokinetic parameters.

Authors and Affiliations

Sameer I. Shaikh, Zahid Zaheer, Santosh N. Mokale, Deepak K. Lokwani

Keywords

Related Articles

DRUG UTILIZATION STUDY AND EVALUATION OF ANTI-HYPERTENSIVE PRESCRIPTIONS FROM MEDICAL REIMBURSEMENT APPLICATIONS AT UNIVERSITY HEALTH CARE FACILITY, BHU, VARANASI

Objective: Pharmacoeconomics evaluates the relationship between clinical, economic, and humanistic outcome for maximizing the value for each monetary unit spent on product and services. So the objective of the study was...

A SIMPLE LIQUID CHROMATOGRAPHIC METHOD FOR SIMULTANEOUS ESTIMATION OF AZITHROMYCIN, FLUCONAZOLE AND ORNIDAZOLE IN BULK AND PHARMACEUTICAL DOSAGE FORMS

Objective: The objective of the study was to develop and validate a new rapid and more sensitive Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) method for the simultaneous estimation of azithromycin, fluc...

UV SPECTROPHOTOMETRIC ESTIMATION OF SUNITINIB MALATE IN PHARMACEUTICAL DOSAGE FORM

Objective: To develop and validate simple zero (D0), first (D1) and second (D2) order derivative UV Spectrophotometric methods for the determination of Sunitinib malate in pharmaceutical dosage form.Methods: Sunitinib ma...

PRELIMINARY STUDIES ON ACALYPHA INDICA: PROXIMATE ANALYSIS AND PHYTOCHEMICAL SCREENING

Objective: This study aims to evaluate the proximate composition and phytochemicals content of Acalypha indica. Methods: The dried samples of root, leaves, stem and whole plant were analysed for protein, total fat, ash,...

RP-UFLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF CLOPIDOGREL, PANTOPRAZOLE AND ROSUVASTATIN IN HUMAN PLASMA: DRUG INTERACTION STUDIES

Objectives: Objective of our present study was to develop a novel ultra fast liquid chromatographic method for quantitative simultaneous estimation of Clopidogrel, Pantoprazole & Rosuvastatin in human plasma and to v...

Download PDF file
  • EP ID EP575447
  • DOI 10.22159/ijpps.2017v9i11.20469
  • Views 95
  • Downloads 0

How To Cite

Sameer I. Shaikh, Zahid Zaheer, Santosh N. Mokale, Deepak K. Lokwani (2017). DEVELOPMENT OF NEW PYRAZOLE HYBRIDS AS ANTITUBERCULAR AGENTS: SYNTHESIS, BIOLOGICAL EVALUATION AND MOLECULAR DOCKING STUDY. International Journal of Pharmacy and Pharmaceutical Sciences, 9(10), 50-56. https://europub.co.uk/articles/-A-575447